D. Scott Coward - Apr 30, 2024 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Director
Signature
/s/ D. Scott Coward by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Apr 30, 2024
Transactions value $
-$4,030
Form type
4
Date filed
5/2/2024, 07:00 PM
Previous filing
Feb 23, 2024
Next filing
Jun 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Award $0 +218 +0.49% $0.00 44.7K Apr 30, 2024 Direct F1
transaction EXAS Common Stock Sale -$4.03K -67 -0.15% $60.15 44.6K May 1, 2024 Direct F2
holding EXAS Common Stock 4.69K Apr 30, 2024 Held in 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024.
F2 Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.